Angiotensin News and Research

RSS
Angiotensin is an oligopeptide in the blood that causes vasoconstriction, increased blood pressure, and release of aldosterone from the adrenal cortex. It is a powerful dipsogen. It is derived from the precursor molecule angiotensinogen, a serum globulin produced in the liver. It plays an important role in the renin-angiotensin system.
Omicron lineage spike proteins use ACE2 receptors more efficiently

Omicron lineage spike proteins use ACE2 receptors more efficiently

Long-term exposure to air pollution associated with greater risk of severe COVID-19

Long-term exposure to air pollution associated with greater risk of severe COVID-19

Link between COVID-19 severity and microbiome of saliva and nasopharynx

Link between COVID-19 severity and microbiome of saliva and nasopharynx

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

Use of RAAS inhibitors reduced aneurysm rupture risk by 18%, finds study

Use of RAAS inhibitors reduced aneurysm rupture risk by 18%, finds study

The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

Inverse relationship identified between SARS-CoV-2 and influenza infections

Inverse relationship identified between SARS-CoV-2 and influenza infections

Study shows the SARS-CoV-2 accessory protein ORF7a inhibits HLA-I surface expression levels in human cells

Study shows the SARS-CoV-2 accessory protein ORF7a inhibits HLA-I surface expression levels in human cells

The pineapple-derived jacalin-related lectin as a potential anti-SARS-CoV-2 agent

The pineapple-derived jacalin-related lectin as a potential anti-SARS-CoV-2 agent

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Exploring virological profiles of recently emerged SARS-CoV-2 Omicron variants

Exploring virological profiles of recently emerged SARS-CoV-2 Omicron variants

Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

Study finds long-term exposure to common air pollutants is associated with COVID-19 severity

Study finds long-term exposure to common air pollutants is associated with COVID-19 severity

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

Cell membrane-bound enzyme is essential for SARS-CoV-2 infectivity, study shows

Cell membrane-bound enzyme is essential for SARS-CoV-2 infectivity, study shows

Gut bacteria can reduce the effectiveness of certain blood pressure drugs

Gut bacteria can reduce the effectiveness of certain blood pressure drugs

Researchers report novel interactions between the SARS-CoV-2 S protein and estrogen receptor alpha

Researchers report novel interactions between the SARS-CoV-2 S protein and estrogen receptor alpha

SARS-CoV-2 variants BA.4 and BA.5 show substantial immune escape compared with BA.1 and BA.2

SARS-CoV-2 variants BA.4 and BA.5 show substantial immune escape compared with BA.1 and BA.2

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.